Pura Vida Investments, LLC Travere Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$20.94 - $30.01 $1.17 Million - $1.68 Million	55,976 Added 50.78%	166,201 $4.03 Million
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $7,083 - $9,180	300 Added 0.27%	110,225 $2.84 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $1.37 Million - $1.75 Million	56,135 Added 104.36%	109,925 $3.41 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $669,664 - $1.29 Million	-51,592 Reduced 48.96%	53,790 $1.3 Million
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $298,440 - $558,386	-21,151 Reduced 16.72%	105,382 $1.54 Million
Q1 2021 May 12, 2021	BUY	$23.37 - $31.77 $2.96 Million - $4.02 Million	126,533 New	126,533 $3.16 Million

198

84.9M

776K

912K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.